Thursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
By Mill Chart
Last update: May 2, 2024
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
Most active stocks
| Ticker | Change | Comment |
|---|---|---|
| EBS | 81.86% | Today, the market has shown strong interest in EMERGENT BIOSOLUTIONS INC (NYSE:EBS) as 136.51M shares have already been traded. Leading to a price increase of 81.86%. Yesterday the company had a press release: Emergent BioSolutions Reports First Quarter 2024 Financial Results. |
| JAGX | 25.51% | JAGUAR HEALTH INC's (NASDAQ:JAGX) traded a high volume of 124.46M shares. Investors witnessed a substantial increase in share prices, with a gain of 25.51%. |
| ALLR | -7.3% | Today, the market has shown strong interest in ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) as 86.85M shares have already been traded. Investors observed a notable downturn in the market as NASDAQ:ALLR experienced a decline of 7.3%. Earlier today the company had a press release: Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer. |
| FFIE | -9.54% | Investors have been actively buying and selling shares of FARADAY FUTURE INTELLIGENT E (NASDAQ:FFIE) in today's session, resulting in a trading volume of 81.91M shares. Investors observed a notable downturn in the market as NASDAQ:FFIE experienced a decline of 9.54%. |
| NIO | 5.12% | Today, there has been significant activity in the market for NIO INC - ADR (NYSE:NIO), with a total trading volume of 72.95M shares. NYSE:NIO is advancing 5.12% today, demonstrating strong growth and market performance. |
| TSLA | -0.02% | The trading session for TESLA INC (NASDAQ:TSLA) has been active, with a total volume of 65.97M shares traded so far today. NASDAQ:TSLA is declining 0.02% today. |
| PTON | -9.01% | 43.97M shares of PELOTON INTERACTIVE INC-A (NASDAQ:PTON) have been traded so far today. Investors observed a notable downturn in the market as NASDAQ:PTON experienced a decline of 9.01%. yesterday the company released their earnings. Yesterday the company had a press release: World of Hyatt and Peloton Team Up with Plans to Reward Members for Wellbeing. |
| NKLA | 2.87% | The trading volume for NIKOLA CORP (NASDAQ:NKLA) has been quite high, with 41.65M shares exchanged. Shares are rising by 2.87%. |
| FCEL | -4.11% | So far, a total of 40.5M shares of FUELCELL ENERGY INC (NASDAQ:FCEL) have been traded in today's session. Investors observed a notable downturn in the market as NASDAQ:FCEL experienced a decline of 4.11%. Earlier today the company had a press release: FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First "Tri-gen" Production System at the Port of Long Beach. |
| PFE | 2.04% | 39.81M shares of PFIZER INC (NYSE:PFE) have been traded so far today. The share price increased by 2.04% today, indicating positive momentum in the market. A press release (Pfizer Reports First-Quarter 2024 Results) was released yesterday. |
Our most active stocks screener will show you the full list.
PFIZER INC
NYSE:PFE (5/31/2024, 7:04:00 PM)
After market: 28.74 +0.08 (+0.28%)28.66
+0.46 (+1.63%)
PFE News
10 hours ago - InvestorPlace3 Discounted Stocks Poised for a Major UpswingExplore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
11 hours ago - InvestorPlaceBlue-Chip Blunders: 7 Stocks to Sell as Management Missteps MountSometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
a day ago - The Motley Fool3 Stocks to Buy for Huge IncomeAll 3 of these stocks have a yield above 5%.
a day ago - Pfizer Inc.Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
a day ago - Takeda Pharmaceutical Company LimitedTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2 days ago - The Motley FoolIs Pfizer the Best Dividend Stock for You?Short-term expectation worries have elevated Pfizer's dividend yield.
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
2 days ago - Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKModerna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
2 days ago - Zacks Investment ResearchPfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2 days ago - CNBCFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
2 days ago - BusinessInsiderQUALCOMM To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
2 days ago - QuartzPfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trialPfizer Chief Oncology Officer Chris Boshoff said the drug could reach $1 billion in annual sales by 2030
